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Introduction: Tendons are highly prone to injury and the intrinsic hypo-
cellularity and hypovascularity make their natural healing extremely
slow and inefficient when severed damaged. Surgical repair with grafts
is common but unsuccessful in a long term basis. The development of
tissue engineering strategies based on stem cells explores a natural
endogenous system of regeneration with potential for tendon applica-
tion. We propose to establish biochemical culturing conditions to assess
the tenogenic potential of human adipose stem cells (hASCs) and
amniotic fluid-derived stem cells (hAFSCs), known for their prolifera-
tive and differentiation capacities. Since several growth factors (GFs)
participate in tendon formation and ECM synthesis, these GFs were
added to the culture medium to stimulate tenogenic differentiation of
these cells(1, 2). This study also envisions the application of hASCs
and/or hAFSCs in cell-based strategies for tendon repair.
Materials and Methods: hASCs were enzymatically isolated from lipoas-
pirates and expanded in basic medium(a-MEM, 10% FBS, 1% antibi-
otic) before being cultured in (i) basic medium, (ii) basic medium with
glutamine(2 mM) and ascorbic acid(0.2 mM) plus (iii) EGF(10 ng/
mL), (iv) FGF(10 ng/mL), (v) PDGF(10 ng/mL) or (vi) TGF-b(10 ng/
mL). hAFSCs were obtained from amniocentesis procedures and
expanded in a-MEM medium plus 15% embryonic screened FBS, 1%
glutamine, 1% antibiotic, 18% Chang B and 2% Chang C. Similarly to
hASCs, hAFSCs were cultured in media (i), (iii), (iv), (v) and (vi) but
(ii) corresponded to hAFSCs expansion medium. Tenogenic differentia-
tion was weekly evaluated up to 28 days based on cell morphology
and Tenascin-C and Collagen3 protein expression, as well as on PCR
analysis for tendon related markers (scleraxis, tenascin C, decorin and
collagen 1 and 3. Primary tenoblasts obtained from surgery surplus
were used as cellular control of the experiment.
Results: hAFSCs and hASCs showed a tenocyte-like aligned distribution
in the different culture media by 14 and 21 days, respectively. But hA-
FSCs tend to lose the typical alignment by growing confluent. Also,
hASCs expressed higher levels of Tenascin-C protein than hAFSCs.
Conclusions: Preliminary data on the aligned morphology and tenas-
cin-C expression shows that both cell sources can be biochemically
induced towards tenogenic features. Overall, and despite variations
found, selected GFs do not actively participate in the tenogenic process
of these cells. Ongoing studies on molecular biology and other tendon
matrix related markers will clarify which stem cell source has more
potential for tendon regeneration strategies.
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Human Embryonic Stem Cells (hESCs) and Induced Pluripotent Stem
Cells (hiPSC) can virtually give rise to all cell types in the body, consti-
tuting an inexhaustible source of relevant cell types. Motor neurons
derived from hESCs and hiPSCs are a potentially important tool to
model and to unravel mechanisms of pathological motor neuron cell
death. The culturing conditions to specify motor neurons (MNs) from
human pluripotent stem cells have been extensively studied and in
general work robustly. However, the production of human motor neu-
rons on a scale compatible with high-throughput studies remains
impractical due to the relatively low yield of current in vitro differentia-
tion protocols. On the other hand, robust survival assays based on puri-
fied human motor neurons have not been developed. Here, we
demonstrate for the first time the presence of ongoing neurogenesis in
human stem cell-derived cultures of mixed spinal cord identity, which
leads to the continuous generation of new-born motor neurons for sev-
eral weeks. We initially exploited this as a means to increase motor
neuron yields and screened a collection of bioactive molecules. The
Rho-associated kinase (ROCK) inhibitor Y-27632 was identified as a
compound that amplifies motor neuron yields up to 4-fold in
differentiated hESC and hiPSC cultures. This likely occurs in a ROCK-
independent manner, through the promotion of proliferation of
Olig2-expressing motor neuron progenitors. Since ongoing neurogene-
sis constitutes a major potential confound for survival assays, amplified
motor neurons expressing the HB9::GFP reporter were therefore FACS-
purified and employed to develop a reproducible and robust survival
assay for human motor neurons. Using this assay, we were capable to
demonstrate for the first time in human motor neurons a significant
survival-promoting activity of an array of known neurotrophic factors
and also showed that Y-27632 itself supports motor neuron survival.
Together, our results highlight Y-27632 as a useful tool to increase
yields of human motor neurons from pluripotent stem cells for cell-
based screening and biochemical applications.
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